Cases from the Osler Medical Service at Johns Hopkins University

American Journal of Medicine

Volumn 113, Issue 9, 2002, Pages 760-762

  Zaas, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

VORICONAZOLE;

ADULT; ARTICLE; BODY TEMPERATURE; CASE REPORT; CIGARETTE SMOKING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE DURATION; DUST EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LABORATORY TEST; LUNG LOBE; MALE; MEDICAL SERVICE; MYCETOMA; NIGHT SWEAT; OXYGEN SATURATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SCEDOSPORIUM APIOSPERMUM; THORAX RADIOGRAPHY; UNIVERSITY; WORK;

EID: 0037115670     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01456-0     Document Type: Note

References (5)

1. Groll A.H., Walsh T.J. Uncommon opportunistic fungi new nosocomial threats . Clin Microbiol Infect. 7:(suppl 2):2001;8-24.
2. Rollot F., Blanche P., Richaud-Thiriez B., et al. Pneumonia due to Scedosporium apiospermum in a patient with HIV infection. Scand J Infect Dis. 2000;32-439.
3. Munoz P., Marin M., Tornero P., et al. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis. 31:2000;1499-1501.
4. Gil-Lamaignere C., Roilides E., Mosquera J., et al. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrob Agents Chemother. 46:2002;2234-2237.
5. Meletiadis J., Meis J.F.G.M., Mouton J.W., et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother. 46:2002;62-68.